BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

Benzinga · 4d ago
BTIG analyst Thomas Shrader reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $8 price target.